Ildong Pharmaceutical (249420) has 5 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩39M ($27K) in reported transaction value. The earliest filing StockDrifts holds for Ildong Pharmaceutical is dated 2024-03-22; the most recent is 2026-04-02. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +89.80%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-04-02 | BUY | Market Buy | 조노제 jonoje | Managing Director | 30 | ₩27,000 | +4.7% | ₩810K ($563) |
| 2026-04-01 | BUY | Market Buy | 조노제 jonoje | Managing Director | 50 | ₩29,350 | -3.7% | ₩1M ($1K) |
| 2026-03-31 | BUY | Market Buy | 조노제 jonoje | Managing Director | 50 | ₩28,050 | +0.8% | ₩1M ($974) |
| 2025-07-01 | BUY | 신규선임 | 서승욱 Seo Seung-wook | Managing Director | 605 | ₩12,660 | +200.9% | ₩8M ($5K) |
| 2025-02-24 | BUY | Market Buy | 최규환 Gyu-hwan Choi | Internal director | 1.0K | ₩11,800 | +222.9% | ₩12M ($8K) |
| 2024-12-24 | BUY | Market Buy | 이승현 Seunghyun Lee | Managing Director | 2.0K | ₩11,750 | +224.3% | ₩24M ($16K) |
| 2024-03-22 | BUY | 신규보고 | 최규환 Gyu-hwan Choi | Internal director | 5.0K | ₩16,870 | +125.8% | ₩84M ($59K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Ildong Pharmaceutical. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.